2024 ICD-10-CM Diagnosis Code E34.8

Other specified endocrine disorders

ICD-10-CM Code:
E34.8
ICD-10 Code for:
Other specified endocrine disorders
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Endocrine, nutritional and metabolic diseases
    (E00–E89)
    • Disorders of other endocrine glands
      (E20-E35)
      • Other endocrine disorders
        (E34)

E34.8 is a billable diagnosis code used to specify a medical diagnosis of other specified endocrine disorders. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal corticosterone
  • Abnormal estradiol
  • Abnormal serotonin
  • Abnormality of serotonin secretion
  • Acrogeria
  • Acroosteolysis
  • Acroosteolysis, keloid-like lesions, premature aging syndrome
  • Aging
  • Atypical Werner syndrome
  • Autoimmune endocrine disease
  • Calcification of pineal gland
  • Complex gonadal endocrine disorder
  • Congenital anomaly of subcutaneous tissue
  • Diabetes mellitus due to genetic defect in insulin action
  • Diabetes mellitus due to genetic defect in insulin action
  • Disorder of androgen receptor
  • Disorder of endocrine gonad
  • Endocrine alopecia
  • Endocrine andrology disorder
  • Endocrine axis dysfunction
  • Euthyroid Graves orbitopathy
  • General adaptation syndrome
  • Glucose-galactose malabsorption
  • Gynecological endocrinology disorder
  • Hereditary acroosteolysis
  • Hutchinson-Gilford syndrome
  • Hypothalamic-pituitary-adrenal axis dysfunction
  • Hypothalamic-pituitary-gonadal axis dysfunction
  • Hypothalamic-pituitary-gonadal axis dysfunction
  • Hypothalamic-pituitary-ovarian axis dysfunction
  • Hypothalamic-pituitary-testicular axis dysfunction
  • Insulin biosynthesis defect
  • Insulin receptor defect
  • Insulin resistance
  • Laminopathy with premature aging
  • Laminopathy with premature aging
  • Laminopathy with premature aging
  • Laminopathy with premature aging
  • Leprechaunism syndrome
  • LMNA-related cardiocutaneous progeria syndrome
  • Macrogenitosomia
  • Macrogenitosomia praecox due to pineal disorder
  • Malabsorption of glucose
  • Mandibular hypoplasia, deafness, progeroid syndrome
  • Marfan's syndrome
  • Mass of endocrine structure
  • Metageria
  • Multiple malformation syndrome with senile-like appearance
  • Neonatal pseudo-hydrocephalic progeroid syndrome
  • Nestor Guillermo progeria syndrome
  • Pineal degeneration
  • Pineal gland disorder
  • Pineal gland dysfunction
  • Premature aging
  • Premature aging syndrome
  • Progeroid and marfanoid aspect, lipodystrophy syndrome
  • Progeroid features, hepatocellular carcinoma predisposition syndrome
  • Progeroid short stature with pigmented nevi
  • Progeroid syndrome Petty type
  • Rabson-Mendenhall syndrome
  • Retinitis pigmentosa, hearing loss, premature aging, short stature, facial dysmorphism syndrome
  • Werner syndrome

Clinical Classification

Clinical Information

  • General Adaptation Syndrome

    the sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress.
  • Werner Syndrome

    an autosomal recessive disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.
  • Werner Syndrome Helicase

    a dna-dependent helicase and 3'-5' exonuclease. it has 3'->5' exonuclease activity towards double-stranded dna with a 5'-overhang and binds preferentially to dna substrates containing alternate secondary structures, such as replication forks and holliday junctions. mutations in the wrn gene are associated with werner syndrome.
  • Insulin Resistance

    diminished effectiveness of insulin in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent hyperglycemia or ketosis.
  • Metabolic Syndrome

    a cluster of symptoms that are risk factors for cardiovascular diseases and type 2 diabetes mellitus. the major components of metabolic syndrome include abdominal obesity; atherogenic dyslipidemia; hypertension; hyperglycemia; insulin resistance; a proinflammatory state; and a prothrombotic (thrombosis) state.
  • Acroosteolysis

    a condition that is characterized by degeneration of the distal phalanges.
  • Homeostatic Model Assessment of Insulin Resistance

    an assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.
  • Hyperandrogenism, Insulin Resistance, Acanthosis Nigricans Syndrome|HAIR-AN Syndrome

    a condition characterized by hyperandrogenism, insulin resistance, and acanthosis nigricans, typically associated with obesity in teenage girls. it is considered to be a subtype of polycystic ovarian syndrome, but may occur in male individuals. etiology is unclear, but some cases may be associated with mutations affecting the tyrosine kinase domain of the insulin receptor.
  • Insulin Receptor Mutation - Associated Insulin Resistance Syndromes

    insulin resistance caused by inactivating mutation(s) in the insr gene encoding the insulin receptor.
  • Insulin Resistance

    decreased sensitivity to circulating insulin which may result in acanthosis nigicrans, elevated insulin level or hyperglycemia.
  • Insulin Resistance Measurement|INSULINR|Insulin Resistance|Insulin Resistance

    the determination of the insulin resistance (cells inability to respond to insulin) in a biological specimen.
  • Insulin Resistance Syndrome

    a cluster of closely related metabolic abnormalities associated with insulin resistance that confer an increased risk of the development of type 2 diabetes and cardiovascular disease. these abnormalities may include obesity, high blood pressure, abnormal cholesterol levels, proteinuria, and/or polycystic ovary syndrome.
  • Insulin Resistant Diabetes Mellitus with Acanthosis Nigricans and Hyperandrogenism|Type A Insulin Resistance Syndrome

    a syndrome of insulin resistance caused by mutation(s) in the insr gene, encoding the insulin receptor. this condition is characterized by a clinical triad of hyperinsulinemia, acanthosis nigricans, and hyperandrogenism without lipodystrophy. this is the least severe of a spectrum of disorders; the other two conditions are rabson-mendenhall syndrome and donohoe syndrome.
  • Obesity-Associated Insulin Resistance

    insulin resistance associated with obesity, which may be attributed in part to impaired insulin signaling in target tissues, or impaired insulin-stimulated glucose transport due to reduced expression of the glucose transporter protein 4.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert E34.8 to ICD-9-CM

  • ICD-9-CM Code: 259.8 - Endocrine disorders NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Endocrine Diseases

Your endocrine system includes eight major glands throughout your body. These glands make hormones. Hormones are chemical messengers. They travel through your bloodstream to tissues or organs. Hormones work slowly and affect body processes from head to toe. These include:

  • Growth and development
  • Metabolism - digestion, elimination, breathing, blood circulation and maintaining body temperature
  • Sexual function
  • Reproduction
  • Mood

If your hormone levels are too high or too low, you may have a hormone disorder. Hormone diseases also occur if your body does not respond to hormones the way it is supposed to. Stress, infection and changes in your blood's fluid and electrolyte balance can also influence hormone levels.

In the United States, the most common endocrine disease is diabetes. There are many others. They are usually treated by controlling how much hormone your body makes. Hormone supplements can help if the problem is too little of a hormone.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.